Assignee

Acucela Inc.

Patents = 95

Trademarks = 10

Forward Citations = 689

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

67 inventors (with patents filed for the assignee):

Acucela Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of innovative therapies for eye diseases. With a focus on preserving and restoring vision, Acucela's pipeline includes novel drug candidates targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. Leveraging their proprietary technologies, Acucela aims to provide much-needed treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com